Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30523206 | 1.00 | CA1 (0.33) | CA1CA2TSHRCA4CA12 | |
| SCHEMBL13991787 | 0.80 | TSHR (0.39) | TSHRALDH1A1 | |
| SCHEMBL13991792 | 0.80 | NOTUM (0.35) | TSHRALDH1A1 | |
| SCHEMBL13991786 | 0.80 | TSHR (0.30) | TSHRALDH1A1 | |
| SCHEMBL13991791 | 0.80 | TSHR (0.30) | TSHRALDH1A1 | |
| SCHEMBL9854203 | 0.76 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL13991790 | 0.74 | VCAM1 (0.40) | TSHRALDH1A1 | |
| SCHEMBL13991793 | 0.74 | ALDH1A1 (0.34) | TSHRALDH1A1 | |
| SCHEMBL29476089 | 0.74 | ALOX15 (0.41) | CA1CA2TSHRCA7ALDH1A1 | |
| SCHEMBL581013 | 0.74 | ALOX15 (0.41) | CA1CA2TSHRCA7ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0431294-A2 | Preparation of 2,4,5-trifluorobenzoic acid by decarboxylation of 3,4,6-trifluorophthalic anhydride | OCCIDENTAL CHEMICAL CORPORATION (US) | 1991-06-12 | — | — | EP | claimed |
| US-4935541-A | Preparation of 2,4,5-trifluorobenzoic acid by decarboxylation of 3,4,6-trifluorophthalic anhydride | OCCIDENTAL CHEMICAL CORPORATION (US) | 1990-06-19 | — | — | US | claimed |
| JP-3161462-A | — | — | None | — | — | JP | disclosed |
| CN-116632353-B | Lithium ion battery electrolyte capable of inhibiting formation and growth of lithium dendrite and lithium ion battery | 江苏兴杰固邦能源科技有限公司 | 2023-10-13 | — | — | CN | disclosed |
| CN-116632353-A | Lithium ion battery electrolyte capable of inhibiting formation and growth of lithium dendrite and lithium ion battery | 江苏兴杰固邦能源科技有限公司 | 2023-08-22 | — | — | CN | disclosed |
| EP-2433933-B1 | PRODUCTION METHOD OF TRI- OR TETRAHALOGEN-SUBSTITUTED PHTHALIDE | SUMITOMO CHEMICAL CO (JP) | 2019-05-08 | — | — | EP | disclosed |
| US-8604221-B2 | Production method of halogen-substituted phthalide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-12-10 | — | — | US | disclosed |
| US-20120142946-A1 | PRODUCTION METHOD OF HALOGEN-SUBSTITUTED PHTHALIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-06-07 | — | — | US | disclosed |
| EP-2433933-A1 | PRODUCTION METHOD OF HALOGEN-SUBSTITUTED PHTHALIDE | Sumitomo Chemical Company, Limited (JP) | 2012-03-28 | — | — | EP | disclosed |
| CN-101529293-A | Flexible optical waveguide, method for producing the same, and epoxy resin composition for flexible optical waveguide | NIPPON CATALYTIC CHEM IND (JP) | 2009-09-09 | — | — | CN | disclosed |
| US-20080305082-A1 | 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof | NOVACEA, INC. | 2008-12-11 | — | — | US | disclosed |
| US-5200556-A | Defluorination in aqueous-alkaline medium using zinc | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-04-06 | — | — | US | disclosed |
| EP-0514863-A2 | Process for preparing 3,4,6-trifluorophthalic acid and its anhydride | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-11-25 | — | — | EP | disclosed |
| JP-H03161462-A | PREPARATION OF 2,4,5-TRIFLUOROBENZOIC ACID BY DECARBOXYLATION OF 3,4,6-TRIFLUOROPHTHALIC ANHYDRIDE | OCCIDENTAL CHEM CORP | 1991-07-11 | — | — | JP | disclosed |
| EP-0431294-A2 | Preparation of 2,4,5-trifluorobenzoic acid by decarboxylation of 3,4,6-trifluorophthalic anhydride | OCCIDENTAL CHEMICAL CORPORATION (US) | 1991-06-12 | — | — | EP | disclosed |
| EP-0431294-A2 | Preparation of 2,4,5-trifluorobenzoic acid by decarboxylation of 3,4,6-trifluorophthalic anhydride | OCCIDENTAL CHEMICAL CORPORATION (US) | 1991-06-12 | — | — | EP | disclosed |
| EP-0431294-A2 | Preparation of 2,4,5-trifluorobenzoic acid by decarboxylation of 3,4,6-trifluorophthalic anhydride | OCCIDENTAL CHEMICAL CORPORATION (US) | 1991-06-12 | — | — | EP | disclosed |
| US-4935541-A | Preparation of 2,4,5-trifluorobenzoic acid by decarboxylation of 3,4,6-trifluorophthalic anhydride | OCCIDENTAL CHEMICAL CORPORATION (US) | 1990-06-19 | — | — | US | disclosed |
| US-4935541-A | Preparation of 2,4,5-trifluorobenzoic acid by decarboxylation of 3,4,6-trifluorophthalic anhydride | OCCIDENTAL CHEMICAL CORPORATION (US) | 1990-06-19 | — | — | US | disclosed |
| US-4935541-A | Preparation of 2,4,5-trifluorobenzoic acid by decarboxylation of 3,4,6-trifluorophthalic anhydride | OCCIDENTAL CHEMICAL CORPORATION (US) | 1990-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080305082-A1 | 1,4-Bis-N-Oxide-5,8- Dihydroxyanthracenedione Compounds and the Use Thereof | RB1, BRCA1, CCNA1 | CA1 4688/4885CA2 4174/4885TSHR 2635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.